Warning letter
Aerosol & Liquid Packaging, Inc.: warning letter of Jul 23, 2003
FDA warning letter UCM147603 · Baltimore District Office
Key facts
| Reference number | UCM147603 |
|---|---|
| Company | Aerosol & Liquid Packaging, Inc. |
| Subject | Quality System Regulations for Medical Devices/Adulterated |
| Issue date | Jul 23, 2003 |
| Posted date | Jul 23, 2003 |
| Issuing office | Baltimore District Office |
| Product type | Devices |
| CFR sections cited | 820, 820.40 |
| Country | 3 |
| Inspection city | Baltimore |
| Inspection ZIP | 21229-5030 |
| Inspection start date | May 13, 2003 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: